Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The symposium is a student focused event and provides the opportunity to learn about all of the exciting research that is being conducted across the Department of Oncology.

Students discussed each other’s research over the course of the day in the poster hall

This year’s Department of Oncology Student Symposium was held on Thursday 22 June in the Richard Doll Building at the Old Road Campus. First year DPhil and MSc by Research students presented scientific posters of their work to date in the three poster sessions. There was a lovely atmosphere around the poster hall, with lots of positive discussion of each other’s work.

Second year DPhil students took the stage in the Richard Doll Lecture Theatre to present their hard work to an audience of their peers in one of four presentation sessions. Each student gave a 10-minute presentation of their work and this was followed by questions from the audience, which were brilliantly chaired by volunteers from among our third- and fourth-year DPhil students. The keynote talk this year was delivered by Professor Colin Goding from the Ludwig Institute. Colin discussed his research in microenvironment-driven phenotype-switching in melanoma biology, which inspired lots of questions and discussion from the audience.

Julius Bannister, winner of the ‘Best Presentation’ prize is presented his award by Professor Mark Middleton Julius Bannister, winner of the ‘Best Presentation’ prize is presented his award by Professor Mark Middleton


Throughout the day our panel of volunteer judges were busily scoring all of the presentations and posters to determine the winner of the ‘Best Presentation’ and ‘Best Poster’ prizes. The ‘Best Presentation’ prize winner was Julius Bannister, from the Blackford Group for his talk on ‘Using orthologue complementation to reveal functional amino acid residues in tumor suppressor proteins’. The winner of the ‘Best Poster’ was Subashan Vadibeler, from the Parkes Group, with his poster on ‘The role of fibroblast ENPP1 expression on anti-tumour immunity’.
 

Students enjoying drinks in The Blackwell Quad at St Cross College at the symposium dinner Students enjoying drinks in The Blackwell Quad at St Cross College at the symposium dinner


 At the end of the day students and staff convened at St Cross College for the symposium dinner. This is the second year we have offered a dinner at the end of the symposium and this initiative has been very well received, with approximately 60 students joining us for dinner this year.

Blog posts

Studying Medical Physics at Oxford: Joshua's Experience

The MSc in Medical Physics with Radiobiology brings together a global student cohort interested in studying at the intersection of physics, biology, and clinical practice. Joshua Webster-Ford studied the MSc in Medical Physics with Radiobiology in 2024, attracted by the diverse curriculum on offer. In this blog, Joshua shares his experience of the course and where it has led him.

Meet Dr Wei-Ting Lu: Exploring Genome Instability in Cancer

Dr Wei-Ting Lu joined the Department of Oncology in September 2025, establishing a research group focused on chromosomal instability and whole genome doubling in cancer. In this blog, Dr Lu shares insights into his lab’s research and the discoveries, both his own and those of others, that sparked his interest in the field.

Beyond the Bench: Lauren's Journey From Cancer Research to Patent Law

After studying the MSc Applied Cancer Science in 2024-2025, Lauren Woodman began her career as a Trainee Patent Attorney. In this blog, she shares her experience of the course and how it inspired her interest in intellectual property law.

International Day of Women and Girls in Science 2026

Today, 11th Feb 2026, is International Day of Women and Girls in Science. To celebrate, our MSc Medical Physics/Radiobiology students honour five pioneering women who shaped nuclear medicine and inspired them on their own journeys in science.

Student Spotlight: Personalised Dosimetry for Radionuclide Therapy

Mark Macsuka is a Clarendon DPhil Scholar in Oncology working on personalised lutetium-177 (177Lu) dosimetry for radionuclide therapies. In this blog, Mark shares insights into the role of AI in cancer treatment and the potential for improved outcomes through personalised treatment approaches.

Blog posts

Studying Medical Physics at Oxford: Joshua's Experience

The MSc in Medical Physics with Radiobiology brings together a global student cohort interested in studying at the intersection of physics, biology, and clinical practice. Joshua Webster-Ford studied the MSc in Medical Physics with Radiobiology in 2024, attracted by the diverse curriculum on offer. In this blog, Joshua shares his experience of the course and where it has led him.

Meet Dr Wei-Ting Lu: Exploring Genome Instability in Cancer

Dr Wei-Ting Lu joined the Department of Oncology in September 2025, establishing a research group focused on chromosomal instability and whole genome doubling in cancer. In this blog, Dr Lu shares insights into his lab’s research and the discoveries, both his own and those of others, that sparked his interest in the field.

Beyond the Bench: Lauren's Journey From Cancer Research to Patent Law

After studying the MSc Applied Cancer Science in 2024-2025, Lauren Woodman began her career as a Trainee Patent Attorney. In this blog, she shares her experience of the course and how it inspired her interest in intellectual property law.

International Day of Women and Girls in Science 2026

Today, 11th Feb 2026, is International Day of Women and Girls in Science. To celebrate, our MSc Medical Physics/Radiobiology students honour five pioneering women who shaped nuclear medicine and inspired them on their own journeys in science.

Student Spotlight: Personalised Dosimetry for Radionuclide Therapy

Mark Macsuka is a Clarendon DPhil Scholar in Oncology working on personalised lutetium-177 (177Lu) dosimetry for radionuclide therapies. In this blog, Mark shares insights into the role of AI in cancer treatment and the potential for improved outcomes through personalised treatment approaches.